PATENT CLAIM ANALYSIS

Application Number: 15866303
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-08
Patent Classification: ["514", "561000"]

Abstract:
The present disclosure provides co-crystals of a substituted glycine compound and a co-former compound of Formula (I): compositions comprising such, and uses thereof in treating and/or reducing the risk for a neuropsychiatric disorder (e.g., schizophrenia, psychotic disorders, depressive disorders, suicidal ideation and/or behavior, obsessive compulsive disorder or Alzheimer's disease). Also provided herein are methods for preparing the co-crystals.

Claim (Index 14):
The co-crystal of  claim 13 , wherein the molecular ratio between the N-methylglycine and fumaric acid in the co-crystal is 1:1, and wherein the co-crystal has a powder X-ray diffraction pattern at a 2\u03b8 angle with peaks (\u00b0) of: 9.81, 11.10, 12.44, 13.99, 15.05, 17.63, 18.65, 19.20, 20.05, 20.80, 20.94, 22.41, 22.60, 23.51, 23.84, 24.61, 25.01, 26.95, 27.25, 28.07, 28.66, 29.23, 29.75, 30.05, 31.85, 33.23, 33.42, 35.49, 36.12, 37.94, 38.15, and 38.58.

Metadata:
- Claim Count in Document: 37.0
- Percentile: 86.0
- Lexical Diversity: 1.35849
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15430750', '15188545', '14358606', '14799281', '14777018']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7803653884899556
- 35 USC 102 Novelty (BERT): 0.5665934073976838
- Combined Prediction Score: 0.7589881903807285
- Mean Citation Score: 320.9926200000001
- Max Citation Score: 471.8377
- Similarity Product: 350.20627357031105

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test